Giant pancreatic cyst with extension to spleen managed by laparoscopy
DOI:
https://doi.org/10.18203/2349-2902.isj20241955Keywords:
Giant pancreatic cysts, Serous cystadenomas, Mucinous cystic neoplasmsAbstract
To review the etiology, clinical presentation, diagnostic evaluation, management, and prognosis of giant pancreatic cysts. Giant pancreatic cysts, defined as cysts exceeding 5 cm in diameter, include a diverse group of lesions such as pseudocysts, serous cystadenomas, mucinous cystic neoplasms (MCNs), and intraductal papillary mucinous neoplasms (IPMNs). Their clinical significance stems from potential complications and the necessity to differentiate benign from malignant cysts. A comprehensive review of the literature was conducted, focusing on the pathophysiology, symptomatology, diagnostic modalities, treatment options, and outcomes associated with giant pancreatic cysts. The etiology of giant pancreatic cysts varies from benign conditions like pseudocysts and serous cystadenomas to potentially malignant or malignant neoplasms such as MCNs and IPMNs. Clinical presentation ranges from asymptomatic cases to severe abdominal symptoms and complications. Diagnostic evaluation includes imaging modalities like ultrasound, CT, MRI/MRCP, and endoscopic ultrasound (EUS) with fine-needle aspiration (FNA) for cytology and biochemical analysis. Management strategies depend on the type and characteristics of the cyst, with options including observation, endoscopic drainage, surgical resection, and percutaneous drainage. The prognosis varies, with benign cysts generally having a favorable outcome, while cysts with malignant potential require timely surgical intervention to improve survival rates. Giant pancreatic cysts pose a diagnostic and therapeutic challenge due to their varied etiologies and potential complications. Accurate diagnosis through advanced imaging and fluid analysis is crucial. Management should be tailored based on the cyst type, symptoms, and malignancy risk, involving a multidisciplinary approach to optimize patient outcomes. Further advancements in diagnostic and therapeutic techniques are anticipated to enhance the management of these complex lesions.
Metrics
References
Gupta A, Chennatt JJ, Mandal C, Gupta J, Krishnasamy S, Bose B, et al. Approach to Cystic Lesions of the Pancreas: Review of Literature. Cureus. 2023;15(3):e36827.
Hu F, Hu Y, Wang D, Ma X, Yue Y, Tang W, et al. Cystic neoplasms of the pancreas: Differential diagnosis and radiology correlation. Frontiers Oncol. 2022;12:860740.
Farrell JJ. Cystic lesions of the pancreas. Yamada's Textbook of Gastroenterology. 2022;1643-65.
Menon G, Hoilat G, Babiker H, Mukkamalla SK. Mucinous cystic pancreatic neoplasms. StatPearls Publishing. 2023.
Jabłońska B, Szmigiel P, Mrowiec S. Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management. World J Gastrointestinal Oncol. 2021;13(12):1880.
Ayoub F, Davis AM, Chapman CG. Pancreatic cysts-an overview and summary of society guidelines. JAMA. 2021;325(4):391-2.
Tan JH, Chin W, Shaikh AL, Zheng S. Pancreatic pseudocyst: Dilemma of its recent management. Experimental Therapeutic Med. 2021;21(2):1.
Misra D, Sood T. Pancreatic pseudocyst. Treasure Island (FL): StatPearls Publishing. 2020.